The failed combination cholesterol medication has made it into the dubious list of top 10 public relations blunders of 2008.
Over $100 million was spent on advertising, including those horrid “Food and Family” television spots that haunt me to this day, yet the data that showed the drug didn’t work as claimed was withheld for 21 months.
It seems that Merck has not learned from their Vioxx debacle, with some saying that “it’s getting tough to find any Merck drug that can hold up to scrutiny.”
Related posts:
- Vytorin, the "besmirched drug du jour"
- Vytorin spin
- "A cure for cancer could be one of the worst mistakes for the United States economy"
- Why you should stop taking Vytorin for high cholesterol
- Is the FDA getting gun shy?
- A 15-year-old performs a C-section
- A jury of "uneducated casino workers" beat the hell out of Merck
KevinMD.com on Facebook
{ 1 comment }
Maybe a PR disaster, maybe a questionable handling of data, but also $1.9 Billion in sales in 2007. I think any company would take that sort of PR Blunder.
Comments on this entry are closed.